journal article·2018-06

Toward Immunocompetent 3D Skin Models

Aleta Pupovac, Berna Senturk, Chiara Griffoni, Katharina Maniura‐Weber, Markus Rottmar, Sally L. McArthur

Advanced Healthcare Materials· Volume 7· Issue 12
Publisher page

Abstract

Abstract 3D human skin models provide a platform for toxicity testing, biomaterials evaluation, and investigation of fundamental biological processes. However, the majority of current in vitro models lack an inflammatory system, vasculature, and other characteristics of native skin, indicating scope for more physiologically complex models. Looking at the immune system, there are a variety of cells that could be integrated to create novel skin models, but to do this effectively it is also necessary to understand the interface between skin biology and tissue engineering as well as the different roles the immune system plays in specific health and disease states. Here, a progress report on skin immunity and current immunocompetent skin models with a focus on construction methods is presented; scaffold and cell choice as well as the requirements of physiologically relevant models are elaborated. The wide range of technological and fundamental challenges that need to be addressed to successfully generate immunocompetent skin models and the steps currently being made globally by researchers as they develop new models are explored. Induced pluripotent stem cells, microfluidic platforms to control the model environment, and new real‐time monitoring techniques capable of probing biochemical processes within the models are discussed.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Organometallic Complex Synthesis and Catalysis · Phosphorus compounds and reactions · Synthetic Organic Chemistry Methods

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Faculty of Science Engineering and Technology Swinburne University of Technology Hawthorn Victoria 3122 Australia

Commonwealth Scientific and Industrial Research Organization (CSIRO) Probing Biosystems Future Science Platform and Manufacturing Clayton Victoria 3168 Australia

Laboratory for Biointerfaces Empa Swiss Federal Laboratories for Materials Science and Technology 9014 St. Gallen Switzerland

Funding

Commonwealth Scientific and Industrial Research Organisation · Fiducie de Recherche sur la Foret des Cantons-de-l'Est · Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

References (88)

Show source-provided references
1. 10.1016/j.addr.2011.01.00510.1016/j.addr.2011.01.005 ↗
2. 10.1016/j.drudis.2016.05.00810.1016/j.drudis.2016.05.008 ↗
3. 10.1515/hsz-2013-027910.1515/hsz-2013-0279 ↗
4. 10.1101/cshperspect.a01533910.1101/cshperspect.a015339 ↗
5. 10.1007/s12015-017-9737-110.1007/s12015-017-9737-1 ↗
6. 10.1089/ten.tec.2013.033510.1089/ten.tec.2013.0335 ↗
7. 10.1038/srep4526210.1038/srep45262 ↗
8. 10.1111/cpr.1237210.1111/cpr.12372 ↗
9. 10.1038/jid.2010.12310.1038/jid.2010.123 ↗
10. 10.1016/j.clindermatol.2011.08.00710.1016/j.clindermatol.2011.08.007 ↗
11. 10.1002/adhm.20160043910.1002/adhm.201600439 ↗
12. 10.1089/adt.2014.57310.1089/adt.2014.573 ↗
13. 10.1016/j.ejpb.2005.03.00410.1016/j.ejpb.2005.03.004 ↗
14. 10.1590/S1516-3180200400010000610.1590/S1516-31802004000100006 ↗
15. 10.1016/j.jaad.2007.08.05010.1016/j.jaad.2007.08.050 ↗
16. 10.1111/j.1365-2672.2004.02181.x10.1111/j.1365-2672.2004.02181.x ↗
17. 10.1089/aivt.2015.001210.1089/aivt.2015.0012 ↗
18. 10.1111/j.1751-1097.2007.00226.x10.1111/j.1751-1097.2007.00226.x ↗
19. 10.1159/00026568110.1159/000265681 ↗
20. 10.1007/978-1-62703-227-8_1910.1007/978-1-62703-227-8_19 ↗
21. 10.1016/S0002-9440(10)63537-710.1016/S0002-9440(10)63537-7 ↗
22. 10.1089/ten.tec.2009.072510.1089/ten.tec.2009.0725 ↗
23. 10.1016/j.exppara.2015.01.00510.1016/j.exppara.2015.01.005 ↗
24. 10.1089/ten.tec.2008.061410.1089/ten.tec.2008.0614 ↗
25. 10.1111/j.0022-202X.2004.23435.x10.1111/j.0022-202X.2004.23435.x ↗
26. 10.1046/j.1365-2133.2000.03287.x10.1046/j.1365-2133.2000.03287.x ↗
27. 10.1371/journal.pone.013671310.1371/journal.pone.0136713 ↗
28. Li L. · J. Visualized Exp. · 2011 · 54 · 2937
29. 10.1016/j.jbiomech.2016.01.04010.1016/j.jbiomech.2016.01.040 ↗
30. 10.1007/s13770-013-1113-x10.1007/s13770-013-1113-x ↗
31. 10.1371/journal.pone.004005810.1371/journal.pone.0040058 ↗
32. 10.1189/jlb.061037410.1189/jlb.0610374 ↗
33. 10.1089/aivt.2014.001010.1089/aivt.2014.0010 ↗
34. 10.1093/infdis/jix15310.1093/infdis/jix153 ↗
35. 10.1089/ten.2006.040510.1089/ten.2006.0405 ↗
36. 10.1088/1758-5082/5/3/03501110.1088/1758-5082/5/3/035011 ↗
37. 10.1016/j.ejcb.2012.06.00410.1016/j.ejcb.2012.06.004 ↗
38. 10.1007/s00403-010-1092-x10.1007/s00403-010-1092-x ↗
39. 10.1016/j.taap.2015.05.01710.1016/j.taap.2015.05.017 ↗
40. 10.1111/wrr.1215410.1111/wrr.12154 ↗
41. 10.1111/joa.1225710.1111/joa.12257 ↗
42. 10.1039/C3BM60319A10.1039/C3BM60319A ↗
43. 10.1007/BF0262413810.1007/BF02624138 ↗
44. 10.1016/0014-4827(89)90422-910.1016/0014-4827(89)90422-9 ↗
45. 10.1126/science.276.5309.7510.1126/science.276.5309.75 ↗
46. Davis G. E. · J. Cell Sci. · 2001 · 114 · 91710.1242/jcs.114.5.917 ↗
47. 10.1046/j.1365-2222.2002.01293.x10.1046/j.1365-2222.2002.01293.x ↗
48. 10.1152/ajplung.90462.200810.1152/ajplung.90462.2008 ↗
49. 10.1155/2012/87574210.1155/2012/875742 ↗
50. 10.1016/j.bjps.2010.03.05110.1016/j.bjps.2010.03.051 ↗
51. 10.1016/j.femsim.2005.03.00810.1016/j.femsim.2005.03.008 ↗
52. 10.1016/j.biocel.2007.12.00510.1016/j.biocel.2007.12.005 ↗
53. 10.1096/fj.13-23178710.1096/fj.13-231787 ↗
54. 10.3390/ma303186310.3390/ma3031863 ↗
55. 10.1021/acsami.7b0401710.1021/acsami.7b04017 ↗
56. 10.1371/journal.pone.014979910.1371/journal.pone.0149799 ↗
57. 10.18632/oncotarget.1094510.18632/oncotarget.10945 ↗
58. 10.1097/GOX.000000000000021910.1097/GOX.0000000000000219 ↗
59. Groeber F. · ALTEX: Altern. Anim. Exp. · 2016 · 33 · 415
60. 10.1089/ten.tea.2015.013910.1089/ten.tea.2015.0139 ↗
61. 10.3389/fimmu.2014.0047910.3389/fimmu.2014.00479 ↗
62. 10.1242/jcs.0047410.1242/jcs.00474 ↗
63. 10.1017/S146239941100194310.1017/S1462399411001943 ↗
64. 10.1007/BF0298271510.1007/BF02982715 ↗
65. 10.1189/jlb.110870210.1189/jlb.1108702 ↗
66. 10.1038/nri244810.1038/nri2448 ↗
67. 10.1016/j.it.2004.09.01510.1016/j.it.2004.09.015 ↗
68. 10.1038/nri173310.1038/nri1733 ↗
69. 10.1038/ni.295610.1038/ni.2956 ↗
70. 10.1016/j.tibtech.2015.04.00310.1016/j.tibtech.2015.04.003 ↗
71. 10.1007/s12015-015-9622-810.1007/s12015-015-9622-8 ↗
72. 10.1002/adhm.20150093610.1002/adhm.201500936 ↗
73. 10.3727/09636890878657646210.3727/096368908786576462 ↗
74. 10.1089/ten.tea.2010.019010.1089/ten.tea.2010.0190 ↗
75. 10.1089/scd.2015.024810.1089/scd.2015.0248 ↗
76. 10.1016/j.stemcr.2016.12.02010.1016/j.stemcr.2016.12.020 ↗
77. 10.1038/jidsymp.2011.510.1038/jidsymp.2011.5 ↗
78. 10.1080/07388551.2016.120915710.1080/07388551.2016.1209157 ↗
79. 10.1007/s40898-017-0003-810.1007/s40898-017-0003-8 ↗
80. 10.1088/1758-5082/2/1/01411110.1088/1758-5082/2/1/014111 ↗
81. 10.1016/j.biomaterials.2014.05.08310.1016/j.biomaterials.2014.05.083 ↗
82. 10.1002/adma.20130550610.1002/adma.201305506 ↗
83. 10.1002/jbm.a.3547310.1002/jbm.a.35473 ↗
84. 10.1155/2016/394348110.1155/2016/3943481 ↗
85. 10.1039/C6LC00229C10.1039/C6LC00229C ↗
86. 10.1172/JCI2852110.1172/JCI28521 ↗
87. 10.1016/j.cytogfr.2014.07.00810.1016/j.cytogfr.2014.07.008 ↗
88. 10.1039/C5CS00567A10.1039/C5CS00567A ↗